Drug Information

Drug General Information
Drug ID
D07FKO
Former ID
DNC013015
Drug Name
N-(2,4-dihydroxybenzyl)-3,4,5-trihydroxybenzamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528063]
Structure
Download
2D MOL

3D MOL
Formula
C14H13NO6
Canonical SMILES
C1=CC(=C(C=C1O)O)CNC(=O)C2=CC(=C(C(=C2)O)O)O
InChI
1S/C14H13NO6/c16-9-2-1-7(10(17)5-9)6-15-14(21)8-3-11(18)13(20)12(19)4-8/h1-5,16-20H,6H2,(H,15,21)
InChIKey
NWUBAFGVRZLIOR-UHFFFAOYSA-N
PubChem Compound ID
44411127
Target and Pathway
Target(s) Tyrosine oxidase Target Info Inhibitor [528063]
BioCyc Pathway (S)-reticuline biosynthesis
Eumelanin biosynthesis
L-dopachrome biosynthesis
KEGG Pathway Tyrosine metabolism
Riboflavin metabolism
Metabolic pathways
Melanogenesis
PathWhiz Pathway Riboflavin Metabolism
Tyrosine Metabolism
WikiPathways Dopamine metabolism
References
Ref 528063Bioorg Med Chem Lett. 2006 May 15;16(10):2682-4. Epub 2006 Mar 2.N-Benzylbenzamides: a new class of potent tyrosinase inhibitors.
Ref 528063Bioorg Med Chem Lett. 2006 May 15;16(10):2682-4. Epub 2006 Mar 2.N-Benzylbenzamides: a new class of potent tyrosinase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.